01/01/2026
As we prepare for 2026, we want to sincerely thank you for your continued trust and partnership. It was an exceptionally busy, with a significant number of important ocular disease findings during 2025.
Among our more serious diagnoses last year were: brain and ocular tumors, multiple lymphomas, sarcoidosis, NAION (non-arteritic ischemic optic neuropathy), tacrolimus toxicity, and even active stroke. We also identified many common but previously undiagnosed conditions, including: glaucoma, retinal tears, and macular degeneration.
We are grateful for the opportunity to play a role in protecting vision and overall health, and we appreciate the confidence you place in our care. We look forward to continuing to serve you in the year ahead.
With sincere thanks,
Best in Sight